Current treatment and future directions in the management of anal cancer
Leila T. Tchelebi(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Nicholas G. Zaorsky(University Hospitals Seidman Cancer Center), Ethan B. Ludmir(The University of Texas MD Anderson Cancer Center), Theodore S. Hong(Massachusetts General Hospital), Cathy Eng(Vanderbilt University), Lisa A. Kachnic(NewYork–Presbyterian Hospital), Craig Messick(The University of Texas MD Anderson Cancer Center)
Cited by 27
Related Papers
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
|Journal of Clinical Oncology|2014|1.1k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
|Journal of Clinical Oncology|2020|827
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
|Journal of Clinical Oncology|2022|580